scholarly journals COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings

2020 ◽  
Vol 119 ◽  
pp. 108153 ◽  
Author(s):  
Laura MacKinnon ◽  
M. Eugenia Socías ◽  
Geoff Bardwell
Author(s):  
Deborah Walker ◽  
Barbara Lannen ◽  
Debra Rossie

Midwifery clinical practice and education has changed significantly since Mary Breckinridge first introduced nurse-midwives to the United States in 1925. This article discusses current challenges in midwifery clinical practice and education and proposes possible solutions. Midwifery clinical challenges include restrictive legislation and business-related barriers, including but not limited to physician supervision restrictions, prescriptive authority, out-of-hospital birth legislation, and third party reimbursement. Educational challenges highlighted include the current healthcare climate’s influence on midwifery education, the contribution of clinical sites and preceptors, and the benefits of midwifery education.


2012 ◽  
Vol 13 (7) ◽  
pp. 611-619 ◽  
Author(s):  
Lisa C. Campbell ◽  
Kristynia Robinson ◽  
Salimah H. Meghani ◽  
April Vallerand ◽  
Michael Schatman ◽  
...  

2015 ◽  
Vol 36 (2) ◽  
pp. 240-253 ◽  
Author(s):  
Shane R. Mueller ◽  
Alexander Y. Walley ◽  
Susan L. Calcaterra ◽  
Jason M. Glanz ◽  
Ingrid A. Binswanger

Author(s):  
Wan-Chun Chang ◽  
Reo Tanoshima ◽  
Colin J.D. Ross ◽  
Bruce C. Carleton

The clinical implementation of pharmacogenetic biomarkers continues to grow as new genetic variants associated with drug outcomes are discovered and validated. The number of drug labels that contain pharmacogenetic information also continues to expand. Published, peer-reviewed clinical practice guidelines have also been developed to support the implementation of pharmacogenetic tests. Incorporating pharmacogenetic information into health care benefits patients as well as clinicians by improving drug safety and reducing empiricism in drug selection. Barriers to the implementation of pharmacogenetic testing remain. This review explores current pharmacogenetic implementation initiatives with a focus on the challenges of pharmacogenetic implementation and potential opportunities to overcome these challenges.


2016 ◽  
Vol 5 (5) ◽  
pp. 507-519 ◽  
Author(s):  
Ian Porter ◽  
Daniela Gonçalves-Bradley ◽  
Ignacio Ricci-Cabello ◽  
Chris Gibbons ◽  
Jaheeda Gangannagaripalli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document